➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

DESONIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Desonide, and when can generic versions of Desonide launch?

Desonide is a drug marketed by Cadila, Cosette, Glenmark Pharms, Perrigo New York, Taro, Teresina, Fougera Pharms, Teligent Pharma Inc, Aleor Dermaceuticals, Encube Ethicals, Glenmark Pharms Ltd, and Hi Tech. and is included in eighteen NDAs.

The generic ingredient in DESONIDE is desonide. There are thirty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the desonide profile page.

US ANDA Litigation and Generic Entry Outlook for Desonide

A generic version of DESONIDE was approved as desonide by TARO on August 3rd, 1994.

  Start Trial

Drug patent expirations by year for DESONIDE
Drug Prices for DESONIDE

See drug prices for DESONIDE

Drug Sales Revenue Trends for DESONIDE

See drug sales revenues for DESONIDE

Recent Clinical Trials for DESONIDE

Identify potential brand extensions & 505(b)(2) entrants

NeoStrata Company, Inc.Phase 3
Massachusetts General HospitalPhase 3
University of California, DavisPhase 1

See all DESONIDE clinical trials

Pharmacology for DESONIDE
Medical Subject Heading (MeSH) Categories for DESONIDE
Paragraph IV (Patent) Challenges for DESONIDE
Tradename Dosage Ingredient NDA Submissiondate
DESONATE GEL;TOPICAL desonide 021844 2010-12-01

US Patents and Regulatory Information for DESONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cadila DESONIDE desonide CREAM;TOPICAL 210198-001 Nov 20, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Teligent Pharma Inc DESONIDE desonide OINTMENT;TOPICAL 212002-001 Mar 12, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Fougera Pharms DESONIDE desonide LOTION;TOPICAL 075860-001 Mar 19, 2002 AB RX No No   Start Trial   Start Trial   Start Trial
Perrigo New York DESONIDE desonide CREAM;TOPICAL 017010-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Encube Ethicals DESONIDE desonide OINTMENT;TOPICAL 210998-001 Jan 30, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Glenmark Pharms DESONIDE desonide LOTION;TOPICAL 209494-001 Sep 26, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.